Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effect of Pramlintide on Meal Time Insulin Bolus

This study has been completed.
Amylin Pharmaceuticals, LLC.
Information provided by:
Diabetes Care Center Identifier:
First received: April 11, 2007
Last updated: April 2, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)